0001415889-21-000237.txt : 20210106 0001415889-21-000237.hdr.sgml : 20210106 20210106180241 ACCESSION NUMBER: 0001415889-21-000237 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210104 FILED AS OF DATE: 20210106 DATE AS OF CHANGE: 20210106 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chapman Steven Leonard CENTRAL INDEX KEY: 0001711968 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37478 FILM NUMBER: 21512049 MAIL ADDRESS: STREET 1: 201 INDUSTRIAL ROAD, SUITE 410 CITY: SAN CARLOS STATE: CA ZIP: 94070 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Natera, Inc. CENTRAL INDEX KEY: 0001604821 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 010894487 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 201 INDUSTRIAL ROAD STREET 2: SUITE 410 CITY: SAN CARLOS STATE: CA ZIP: 94070 BUSINESS PHONE: 650-249-9090 MAIL ADDRESS: STREET 1: 201 INDUSTRIAL ROAD STREET 2: SUITE 410 CITY: SAN CARLOS STATE: CA ZIP: 94070 4 1 form4-01062021_030131.xml X0306 4 2021-01-04 0001604821 Natera, Inc. NTRA 0001711968 Chapman Steven Leonard C/O NATERA, INC. 201 INDUSTRIAL RD SUITE 410 SAN CARLOS CA 94070 true true false false CHIEF EXECUTIVE OFFICER Common Stock 2021-01-04 4 M 0 3125 A 38722 D Common Stock 2021-01-04 4 M 0 335 10.41 A 39057 D Common Stock 2021-01-04 4 M 0 104 10.73 A 39161 D Common Stock 2021-01-04 4 M 0 153 9.29 A 39314 D Common Stock 2021-01-04 4 M 0 313 13.01 A 39627 D Common Stock 2021-01-04 4 M 0 1875 13.01 A 41502 D Common Stock 2021-01-04 4 M 0 313 20.27 A 41815 D Common Stock 2021-01-04 4 M 0 239 25.46 A 42054 D Common Stock 2021-01-04 4 S 0 1558 99.49 D 40496 D Common Stock 2021-01-04 4 S 0 3332 99.49 D 37164 D Restricted Stock Unit 2021-01-04 4 M 0 3125 0 D Common Stock 3125 25000 D Stock Option (right to buy) 10.41 2021-01-04 4 M 0 335 0 D 2027-06-08 Common Stock 335 10837 D Stock Option (right to buy) 10.73 2021-01-04 4 M 0 104 0 D 2027-07-13 Common Stock 104 5105 D Stock Option (right to buy) 9.29 2021-01-04 4 M 0 153 0 D 2028-03-08 Common Stock 153 48687 D Stock Option (right to buy) 13.01 2021-01-04 4 M 0 313 0 D 2029-01-10 Common Stock 313 53854 D Stock Option (right to buy) 13.01 2021-01-04 4 M 0 1875 0 D 2029-01-10 Common Stock 1875 79375 D Stock Option (right to buy) 20.27 2021-01-04 4 M 0 313 0 D 2029-04-11 Common Stock 313 60104 D Stock Option (right to buy) 25.46 2021-01-04 4 M 0 239 0 D 2030-03-26 Common Stock 239 42031 D Represents the partial vesting and settlement of Restricted Stock Units ("RSUs"), starting on January 2, 2020. Each RSU represents a contingent right to receive one share of the common stock of the issuer. The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs pursuant to Rule 10b5-1. The sales reported in this Form 4 effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2020. The RSUs vest over four years. 25% of the RSUs vested on January 2, 2020 and the remaining shares vest in 12 equal quarterly installments thereafter. The option shares vest over four years. 25% of the option shares vested and became exercisable on March 21, 2018 and the remaining shares vest in 36 equal monthly installments thereafter. The option shares vest over four years. 25% of the option shares vested and became exercisable on March 12, 2018 and the remaining shares vest in 36 equal monthly installments thereafter. The option shares vest over four years. 25% of the option shares vested and became exercisable on March 9, 2019 and the remaining shares vest in 36 equal monthly installments thereafter. The option shares vest over four years. 25% of the option shares vested and became exercisable on January 2, 2020 and the remaining shares vest in 36 equal monthly installments thereafter. This option becomes exercisable, if at all, upon the Reporting Person achieving certain milestones relating to a combination of the passage of time and the Reporting Person achieving certain milestones relating to the Issuer's stock price, based on the average closing price per share of the Issuer's common stock for a calendar month, calculated as of the last day of such calendar month. The first milestone is the Issuer's stock price equaling or exceeding the quotient of (i) $2,000,000,000 and (ii) the Issuer's outstanding shares as most recently reported on the Issuer's Form 10-Q or Form 10-K (the "Capitalization"). The second milestone is the Issuer's stock price equaling or exceeding the quotient of (i) $3,000,000,000 and (ii) the Capitalization (the "Performance Vesting Conditions"). As of December 18, 2020, the Company's Board of Director determined the performance criteria had been met with respect to 18,750 additional shares. The option shares vest over four years. 25% of the option shares vested and became exercisable on March 22, 2020 and the remaining shares vest in 36 equal monthly installments thereafter. The option vests upon the Reporting Person achieving certain milestones relating to a combination of the passage of time and the Reporting Person achieving certain milestones relating to the Issuer's stock price. As of October 1, 2020, the Company's Board of Director determined the performance criteria had been met with respect to 37,500 shares. /s/ Tami Chen, Attorney-in-Fact 2020-01-06